Drug
Apl2
Apl2: highest development phase Phase 2/3, developed by Apellis Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Apellis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| APL2 NCT07213960 | Phase 2/3 | FSGS |
Latest
No recent events.
Follow Apl2 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.